A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3

Hess, K; Alzahrani, S H; Mathai, M; Schroeder, V; Carter, A M; Howell, G; Koko, T; Strachan, M W J; Price, J F; Smith, K A; Grant, P J; Ajjan, R A (2012). A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3. Diabetologia, 55(4), pp. 1103-13. Heidelberg: Springer 10.1007/s00125-011-2301-7

Full text not available from this repository. (Request a copy)

Impaired fibrin clot lysis is a key abnormality in diabetes and complement C3 is one protein identified in blood clots. This work investigates the mechanistic pathways linking C3 and hypofibrinolysis in diabetes using ex vivo/in vitro studies.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Schröder, Verena

ISSN:

0012-186X

Publisher:

Springer

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:35

Last Modified:

17 Mar 2015 21:24

Publisher DOI:

10.1007/s00125-011-2301-7

PubMed ID:

21918806

Web of Science ID:

000301182000026

URI:

https://boris.unibe.ch/id/eprint/13829 (FactScience: 220495)

Actions (login required)

Edit item Edit item
Provide Feedback